INNBCL Coin Very Nice Future x1000
Wow, it only took a +1000% profit for getting some attention here
Topic: [ANN][INNBC]INNOVATIVE BIORESEARCH 💚 Funding AIDS cure research*get JDM cars 🚗 (Read 17906 times)
March 30, 2019, 02:41:54 PM
Wow, it only took a +1000% profit for getting some attention here
October 22, 2018, 07:02:31 AM
July 29, 2018, 08:52:11 AM
July 27, 2018, 06:58:46 PM
ICO will close 1 Aug 2018.
July 17, 2018, 01:43:08 AM
July 14, 2018, 06:44:40 PM
Good. Our community is growing really fast.
Main telegram group 99k memebers
https://t.me/innovativebioresearch
Second group 2k members
https://t.me/innbc
Telegram channel 9.6k memebers
https://t.me/InnbcChannel
Twitter 6.3k followers
https://twitter.com/InnBioresearch
Main telegram group 99k memebers
https://t.me/innovativebioresearch
Second group 2k members
https://t.me/innbc
Telegram channel 9.6k memebers
https://t.me/InnbcChannel
Twitter 6.3k followers
https://twitter.com/InnBioresearch
July 14, 2018, 03:14:37 PM
July 12, 2018, 07:32:31 AM
July 09, 2018, 12:28:59 PM
Announcement came earlier and it's already out.
This is a huge news.
We are very excited to announce our official partnership with the French multinational electronics company ARCHOS (https://www.archos.com).
ARCHOS partners with INNOVATIVE BIORESEARCH to promote its ARCHOS Safe-T mini towards crypto-enthusiasts while taking part to the development of medicinal research through the blockchain
Paris / London – Monday, July 9th 2018 – ARCHOS, the French pioneer of consumer electronics, announces today a partnership with INNOVATIVE BIORESEARCH, a biotech company bringing innovation to the field of cancer, HIV and regeneration research.
INNOVATIVE BIORESEARCH is building up an application based upon the blockchain technology. It consists in a decentralized database for clinical data and in a social platform for the HIV seropositive community. It allows clinicians and patients from all over the world to share and access consolidated clinical information in order to start direct trials and treatments faster.
To finance the needed development of this revolutionary platform, INNOVATIVE BIORESEARCH successfully ended the pre-sale of their INNBC Tokens, with INNBC valued 1€, and a very successful airdrop.
“With our Safe T mini, we offer a superior level of security to all ICOs investors We are very proud to partner with Jonathan Fior and the INNOVATIVE BIORESEARCH’ team. We are fully confident the blockchain technology is a key contributor in the healthcare industry”, declares Loïc Poirier, CEO of ARCHOS.
Under the terms of their agreement, ARCHOS is pursuing the promotion of the Safe Mini T, its cold storage hardware wallet delivering the highest security level to keep crypto assets safe offline. INNOVATIVE BIORESEARCH will organize a selling event via its 99,000 Telegram groups where users will be able to register and get a voucher to buy the ARCHOS Safe-T mini. For each sale, 3€ will be devoted by ARCHOS to INNOVATIVE BIORESEARCH’ ICO.
“Our test of the ARCHOS Safe-T mini has been very positive. We are happy to offer a special bonus to our community: the first 10,000 people purchasing their ARCHOS Safe-T mini with our voucher will receive 39 INNBC tokens, valued 39€, from INNOVATIVE BIORESEARCH”, adds Jonathan Fior, Founder and CEO of INNOVATIVE BIORESEARCH.
About ARCHOS
ARCHOS, a pioneer in consumer electronics, continues to innovate and revolutionize the consumer electronics market. Among others, the French manufacturer was first with an HDD MP3 player in 2000, a multimedia player in 2003, Google Android powered tablets in 2009, a connected Smart Home in 2014 and PicoWAN, the first collaborative network dedicated to the IoT, in 2016. Today, ARCHOS designs and democratizes solutions with high innovation value: tablets and smartphones, home and IoT, urban mobility and security of blockchains. With headquarters in France, offices in Europe and in Asia, ARCHOS has become a strong pan-European player. ARCHOS is quoted on Compartment C of Eurolist, Euronext Paris, ISIN Code: FR0000182479.
Press contacts ARCHOS
Bénédicte Ernoult – [email protected] - +33 (0)1 69 33 16 90
Emmanuelle Bureau du Colombier – [email protected] - + 33 (0)6 09 47 23 49
ARCHOS’ official Telegram group: https://t.me/ArchosCrypto
About INNOVATIVE BIORESEARCH
Innovative Bioresearch Ltd (https://www.innovativebioresearch.com) is a privately held biotech company founded by research scientist Jonathan Fior, with the goal of bringing innovation to the field of HIV, cancer and regeneration research. In 2012, Jonathan Fior conceived SupT1 cell infusion therapy, a novel cell-based therapy for HIV using SupT1 cells as a “decoy target” for the HIV virus to prevent CD4+ T cell depletion as well as to render the virus less cytopathic. Using a standardized T cell line such as the SupT1 cell line should significantly reduce the treatment costs, allowing access to the therapy where access to traditional HIV therapies is restricted by economic and social limitations. In addition, Innovative Bioresearch is studying salamander regeneration as a model for developing novel regenerative and anti-cancer therapies. In 2018, Innovative Bioresearch relocated their business from Italy to the UK and entered the Crypto space launching their own cryptocurrency, the InnovativeBioresearchCoin, INNBC.
Press contacts INNOVATIVE BIORESEARCH
Jonathan Fior – [email protected] – + 39 370 337 0489
INNOVATIVE BIORESEARCH’ official Telegram groups:
https://t.me/innovativebioresearch
https://t.me/innbc
View original content with multimedia: https://www.archos.com/corporate/press/press_releases/EN_PR_ARCHOS_Innovative_Bioresearch_20180709.pdf
This is a huge news.
We are very excited to announce our official partnership with the French multinational electronics company ARCHOS (https://www.archos.com).
ARCHOS partners with INNOVATIVE BIORESEARCH to promote its ARCHOS Safe-T mini towards crypto-enthusiasts while taking part to the development of medicinal research through the blockchain
Paris / London – Monday, July 9th 2018 – ARCHOS, the French pioneer of consumer electronics, announces today a partnership with INNOVATIVE BIORESEARCH, a biotech company bringing innovation to the field of cancer, HIV and regeneration research.
INNOVATIVE BIORESEARCH is building up an application based upon the blockchain technology. It consists in a decentralized database for clinical data and in a social platform for the HIV seropositive community. It allows clinicians and patients from all over the world to share and access consolidated clinical information in order to start direct trials and treatments faster.
To finance the needed development of this revolutionary platform, INNOVATIVE BIORESEARCH successfully ended the pre-sale of their INNBC Tokens, with INNBC valued 1€, and a very successful airdrop.
“With our Safe T mini, we offer a superior level of security to all ICOs investors We are very proud to partner with Jonathan Fior and the INNOVATIVE BIORESEARCH’ team. We are fully confident the blockchain technology is a key contributor in the healthcare industry”, declares Loïc Poirier, CEO of ARCHOS.
Under the terms of their agreement, ARCHOS is pursuing the promotion of the Safe Mini T, its cold storage hardware wallet delivering the highest security level to keep crypto assets safe offline. INNOVATIVE BIORESEARCH will organize a selling event via its 99,000 Telegram groups where users will be able to register and get a voucher to buy the ARCHOS Safe-T mini. For each sale, 3€ will be devoted by ARCHOS to INNOVATIVE BIORESEARCH’ ICO.
“Our test of the ARCHOS Safe-T mini has been very positive. We are happy to offer a special bonus to our community: the first 10,000 people purchasing their ARCHOS Safe-T mini with our voucher will receive 39 INNBC tokens, valued 39€, from INNOVATIVE BIORESEARCH”, adds Jonathan Fior, Founder and CEO of INNOVATIVE BIORESEARCH.
About ARCHOS
ARCHOS, a pioneer in consumer electronics, continues to innovate and revolutionize the consumer electronics market. Among others, the French manufacturer was first with an HDD MP3 player in 2000, a multimedia player in 2003, Google Android powered tablets in 2009, a connected Smart Home in 2014 and PicoWAN, the first collaborative network dedicated to the IoT, in 2016. Today, ARCHOS designs and democratizes solutions with high innovation value: tablets and smartphones, home and IoT, urban mobility and security of blockchains. With headquarters in France, offices in Europe and in Asia, ARCHOS has become a strong pan-European player. ARCHOS is quoted on Compartment C of Eurolist, Euronext Paris, ISIN Code: FR0000182479.
Press contacts ARCHOS
Bénédicte Ernoult – [email protected] - +33 (0)1 69 33 16 90
Emmanuelle Bureau du Colombier – [email protected] - + 33 (0)6 09 47 23 49
ARCHOS’ official Telegram group: https://t.me/ArchosCrypto
About INNOVATIVE BIORESEARCH
Innovative Bioresearch Ltd (https://www.innovativebioresearch.com) is a privately held biotech company founded by research scientist Jonathan Fior, with the goal of bringing innovation to the field of HIV, cancer and regeneration research. In 2012, Jonathan Fior conceived SupT1 cell infusion therapy, a novel cell-based therapy for HIV using SupT1 cells as a “decoy target” for the HIV virus to prevent CD4+ T cell depletion as well as to render the virus less cytopathic. Using a standardized T cell line such as the SupT1 cell line should significantly reduce the treatment costs, allowing access to the therapy where access to traditional HIV therapies is restricted by economic and social limitations. In addition, Innovative Bioresearch is studying salamander regeneration as a model for developing novel regenerative and anti-cancer therapies. In 2018, Innovative Bioresearch relocated their business from Italy to the UK and entered the Crypto space launching their own cryptocurrency, the InnovativeBioresearchCoin, INNBC.
Press contacts INNOVATIVE BIORESEARCH
Jonathan Fior – [email protected] – + 39 370 337 0489
INNOVATIVE BIORESEARCH’ official Telegram groups:
https://t.me/innovativebioresearch
https://t.me/innbc
View original content with multimedia: https://www.archos.com/corporate/press/press_releases/EN_PR_ARCHOS_Innovative_Bioresearch_20180709.pdf
July 09, 2018, 08:47:29 AM
Stay tuned for a big announcement for tomorrow.
July 08, 2018, 03:05:37 AM
We are expanding so fast that we reached the 100K limit of our Telegram group, and we opened a second Telegram group. We aim to reach 200k Telegram members. None of the other ICOs has a 200k Telegram gropup.
July 05, 2018, 12:57:18 AM
GOOD NEWS
Nice. Coin predictor says our INNBC Token could see a 100% appreciacion once the Token is listed on exchanges. https://coinpredictor.io/icos/innovative-bioresearch
http://spiderman22.altervista.org/36644174_1744777088940928_1134715310037794816_n.jpg
Nice. Coin predictor says our INNBC Token could see a 100% appreciacion once the Token is listed on exchanges. https://coinpredictor.io/icos/innovative-bioresearch
http://spiderman22.altervista.org/36644174_1744777088940928_1134715310037794816_n.jpg
July 01, 2018, 12:50:33 PM
Our Telegram group is exploding, we now have 99k members.
June 30, 2018, 09:08:40 AM
June 28, 2018, 07:45:43 PM
June 20, 2018, 06:05:17 AM
We have a very great news for INNBC Token investors and bounty participants.
-The INNBC Token is about to get listed on Forkdelta. We have a listing request under review right now. So you will be able to trade your Token very soon.
-The bounty participants were supposed to get their Tokens at the end of the ICO, which means 1 Aug. We understand that waiting till 1 Aug is frustrating for you, and we want to compensate your hard work. So we decided to issue bounty Tokens earlier. How much earlier? Well, real soon, so stay tuned for the next update😎👍
http://spiderman22.altervista.org/tokens.png
-The INNBC Token is about to get listed on Forkdelta. We have a listing request under review right now. So you will be able to trade your Token very soon.
-The bounty participants were supposed to get their Tokens at the end of the ICO, which means 1 Aug. We understand that waiting till 1 Aug is frustrating for you, and we want to compensate your hard work. So we decided to issue bounty Tokens earlier. How much earlier? Well, real soon, so stay tuned for the next update😎👍
http://spiderman22.altervista.org/tokens.png
June 16, 2018, 12:16:22 AM
Innovative Bioresearch ICO got listed on ICO Channels with an impressive 82 score 😁😎👍
https://icochannels.com/published/details/innbc-431.html
https://icochannels.com/published/details/innbc-431.html
June 15, 2018, 06:49:40 PM
New very nice article about our biotech ICO
https://myicoreviews.com/innbc-implementing-the-blockchain-to-end-hiv-aids-ii/
https://myicoreviews.com/innbc-implementing-the-blockchain-to-end-hiv-aids-ii/
June 15, 2018, 05:10:18 PM
June 14, 2018, 06:33:03 AM
New advisor on board, we welcome Raghav Sawhney, CMO at BlockChainPRBuzz, as strategy advisor for our ICO.
https://www.innovativebioresearch.com/about
CMO at BlockChainPRBuzz and where he have worked with around 55 ICO's, consulted them and holds the position of Marketing Advisor in several of these projects. Every customer should be provide with autonomy of valuable choice and I try to ensure value for all my clients. With the experience of working with many clients, he aspire to change the ideology that exists towards sales. A person with entrepreneurial skill set, he is looking forward to evolve various business processes.
https://www.innovativebioresearch.com/about
CMO at BlockChainPRBuzz and where he have worked with around 55 ICO's, consulted them and holds the position of Marketing Advisor in several of these projects. Every customer should be provide with autonomy of valuable choice and I try to ensure value for all my clients. With the experience of working with many clients, he aspire to change the ideology that exists towards sales. A person with entrepreneurial skill set, he is looking forward to evolve various business processes.
Jump to: